These findings are based on past reported effects of a phase III trial, indicating that immediate viral load relief may prevent infection after exposure to COVID-19. In addition, SaNOtize is investigating whether the spray can be effective only as a prophylactic measure.
Glenmark’s Phase III clinical trial of SaNOtize’s Nitric Oxide Nasal Spray found remarkable relief in SARS-CoV-2 viral load of 94% within 24 hours and more than 99% within 48 hours, according to the brand. Nitric oxide nasal spray acts proactively and as a tool to lower viral load. It neutralizes viruses well in the nasal cavity, the main entry point for viruses into the respiratory tract, thus particularly reducing the viral load in the body. Plus, it’s easy to use and made exclusively from herbs. ingredients.
“SaNOtize Nasal Spray represents an important step forward in our efforts to combat COVID-19. Backed by compelling studies and clinical trials, we’ve noticed noticeable discounts in viral load. “The product stands out for its safety, plant composition and ease of use, which is a valuable asset in the ongoing fight against respiratory infections,” says the logo’s spokesperson.
SaNOtize Nasal Spray offers free international shipping and has a long shelf life, making it a convenient and available option for others looking for your coverage against viral infections.
For more information and to order Enovid Nasal Spray, visit BuyEnov’s official online page in https://buyenov. com/
BuyEnov is a leading medicine logistics company based in Israel. Recognized for its support of global visitors and professionals, BuyEnov provides access to high-quality prescription and over-the-counter medications. The company has been known for introducing SaNOtize’, the nasal nitric oxide spray (NONS), which provides additional defense against viral infections.
SaNOtize Nitric Oxide Nasal Spray is available as a medical device in Thailand, Singapore, Hong Kong, South Africa, Malaysia, Cambodia, Germany (under the logo called VirX™), Israel, Indonesia, and Bahrain (under the logo called enovid™). ). It can also be purchased in India, by prescription, under the name FabiSpray. It is not yet approved for sale in Canada or the United States.
VirX™ and enovid™ are the same formulations and involve the same active ingredients and mechanisms of action as nasal therapies used in clinical trials. Nothing involved in this segment should be construed as a solicitation, promotion, or advertising of any drug or medical device, adding to the principles discussed in this segment. Any product information involved herein is not intended to provide medical advice nor should it be used as a replacement for recommendations provided through a physician or other health care professional.
Enovid, VirX and FabiSpray are trademarks and are owned by SaNotize, a company in Vancouver, Canada.
© 2023 Benzinga. com. Benzinga provides investment advice. All rights reserved.